In this issue:
Smoking cessation and risk of developing psoriasis
Cumulative methotrexate dose and liver fibrosis
Apremilast for psoriasis
Burden of topical treatments
Biologic therapy for psoriasis and risk of cutaneous infections
Roflumilast cream 0.3% in adults with chronic plaque psoriasis
Guselkumab vs adalimumab: disease- and mechanism-related biomarkers
Digital media use among German patients with psoriasis
Please login below to download this issue (PDF)